Bacillus Calmette-Guérin treatment and vesicorenal reflux.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2311637.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
14 patients with radiologically documented vesicorenal reflux (5 bilateral, 7 unilateral, 2 unilateral double-J stents) received intravesical immunotherapy with bacillus Calmette-Guérin (BCG) after treatment of their superficial urothelial tumors. 1 patient with a double-J stent suffered a highly febrile attack following obstruction of the indwelling ureteral catheter. The other patients tolerated 1 or 2 (6 of 14 patients) courses of BCG without an increase in side effects. Topical intravesical therapy with BCG in patients with vesicorenal reflux seems to be indicated in view of the multicentricity of urothelial carcinoma and can be performed without an increased risk of complications.
Medical subject headings
- BCG Vaccine
- Carcinoma, Transitional Cell
- Kidney Diseases
- Urinary Bladder Diseases
- Urinary Bladder Neoplasms